For Watson CEO Bisaro, “Operational Efficiency” Is An Industry-Wide Calling

Contaminated heparin continues to create regulatory fallout worldwide, so one might think that this would not be a particularly good time to press FDA to loosen its manufacturing oversight

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet